At the 4th Annual Dermatology Drug Development Summit Europe on May 22-24, 2023, in Berlin, Germany, UNION therapeutics A/S (UNION) CEO Dr. Kim D. Kjøller will take the stage to discuss the current landscape of treatments for hidradenitis suppurativa (HS).
Dr. Kjøller will provide insight into new and improved ways to tackle this chronic, debilitating skin disorder and better develop treatments across the fields of dermatology and immunology. Don’t miss this opportunity to learn from one of the top minds in the field and be at the forefront of HS treatment advancements.
Dr. Kjøller is excited to be hosting a pre-conference workshop on “Dermatological Development Strategies: Setting yourself up for success and reducing time to market” on Monday, May 22nd, 2023, from 1-4pm CEST. This insightful workshop will provide invaluable strategies and insights to help you achieve success and reduce time to market for your dermatological product.
Don’t miss out on this amazing opportunity to gain invaluable knowledge and insights from one of the industry’s leading experts!
About UNION therapeutics
UNION therapeutics is an innovative, forward-thinking pharmaceutical development company that’s leading the way in immunology and infectious diseases. With a team of experienced biotech entrepreneurs and seasoned pharma executives with a proven track record of success, UNION is based in Hellerup, Denmark and is dedicated to creating novel treatment options to help those in need. With fifteen already launched drugs, UNION is striving to make a lasting impact on the lives of those around the world.